Centessa Pharmaceuticals plc

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Total revenue	0.02	0.00	0.01	0.00		0.00	0.00
Cost of revenue		0.00	0.00	0.00	0.00
Gross profit	0.02	0.00	0.01	0.00	0.00
Total operating expenses +	0.22	0.20	0.18	0.21	0.37	0.01	0.01
Selling, general and administrative	0.05	0.05	0.05	0.06	0.04	0.00	0.00
Research and development	0.17	0.15	0.12	0.16	0.10	0.01	0.00
Other operating expenses	0.00	0.00	0.00	0.00	0.24	0.00	0.00
Operating income	-0.21	-0.20	-0.17	-0.21	-0.37	-0.01	-0.01
Non-operating income (net)	0.01	-0.03	0.00	0.00	-0.01	0.00	0.00
Income before tax	-0.20	-0.23	-0.18	-0.22	-0.38	-0.01	-0.01
Income tax expense	0.00	0.00	-0.03	0.00	0.00	0.00	0.00
Net income	-0.20	-0.24	-0.15	-0.22	-0.38	-0.01	-0.01

Show Quarterly Income Statement

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20
Total revenue	0.00	0.00	0.00	0.00	0.02	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cost of revenue	0.00			0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.00
Gross profit	0.00			0.00	0.02	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.00
Total operating expenses +	0.08	0.07	0.05	0.05	0.05	0.07	0.05	0.04	0.04	0.04	0.04	0.05	0.05	0.04	0.05	0.07	0.05	0.05	0.04	0.04	0.24	0.00	0.00	0.00	0.00
Selling, general and administrative	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00
Research and development	0.06	0.05	0.04	0.04	0.03	0.06	0.03	0.03	0.02	0.03	0.03	0.03	0.03	0.03	0.04	0.05	0.04	0.05	0.03	0.02	0.23	0.00	0.00	0.00	0.00
Other operating expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00
Operating income	-0.08	-0.07	-0.05	-0.05	-0.03	-0.07	-0.05	-0.04	-0.04	-0.04	-0.04	-0.05	-0.05	-0.04	-0.05	-0.07	-0.05	-0.06	-0.04	-0.04	-0.24	0.00	0.00	0.00	0.00
Non-operating income (net)	0.00	0.00	0.00	0.01	0.01	-0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Income before tax	-0.08	-0.07	-0.05	-0.05	-0.02	-0.11	-0.04	-0.04	-0.04	-0.04	-0.04	-0.05	-0.05	-0.04	-0.05	-0.06	-0.05	-0.06	-0.04	-0.04	-0.24	0.00	0.00	0.00	0.00
Income tax expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	0.00		0.00	0.00	0.00
Net income	-0.08	-0.07	-0.05	-0.05	-0.03	-0.11	-0.04	-0.04	-0.04	-0.04	-0.04	-0.02	-0.05	-0.04	-0.05	-0.06	-0.05	-0.06	-0.04	-0.04	-0.24	0.00	0.00	0.00	0.00

1 day ago

Ask a follow up

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Total cash and short-term investments +	0.29	0.48	0.26	0.39	0.60	0.01	0.00
Cash and cash equivalents	0.06	0.38	0.13	0.39	0.60	0.01
Short-term investments	0.23	0.10	0.13	0.00
Accounts receivable, net		0.05	0.04	0.03	0.02	0.00
Inventories			0.00	-0.03	-0.02	0.00
Other current assets	0.07	0.01	0.02	0.02	0.02	0.00	0.00
Total current assets	0.37	0.54	0.32	0.44	0.63	0.01	0.02
Total non-current assets +	0.32	0.04	0.05	0.01	0.00	0.00
Property, plant and equipment, net				0.00	0.00
Goodwill
Intangible assets
Long-term investments	0.28	0.00
Other non-current assets
Total assets	0.69	0.58	0.36	0.44	0.63	0.01	0.02

Total current liabilities +	0.04	0.06	0.04	0.04	0.02	0.01	0.00
Accounts payable	0.01	0.01	0.01	0.01	0.01	0.00
Short-term debt						0.01	0.00
Current portion of long-term debt						0.01
Deferred revenue
Other current liabilities	0.04	0.05	0.03	0.02	0.02	0.00
Total non-current liabilities +	0.12	0.12	0.08	0.07	0.11	0.03
Long-term debt	0.11	0.11	0.08	0.07	0.08		0.00
Capital lease obligations	0.01	0.01	0.01	0.00
Other non-current liabilities	0.00	0.00	0.00	0.04	0.00
Total liabilities	0.16	0.18	0.12	0.11	0.14	0.01	0.01

Total stockholders' equity +	0.53	0.40	0.24	0.34	0.49	0.00	0.01
Common stock and paid-in capital	1.71	1.39	0.99	0.94	0.88	0.03	0.03
Retained earnings	-1.19	-0.99	-0.75	-0.60	-0.39	-0.02	-0.01
Common shares outstanding	136	114	96	93	90	71	106

Show Quarterly Balance Sheet

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20
Total cash and short-term investments +	0.28	0.29	0.25	0.25	0.28	0.48	0.52	0.29	0.23	0.26	0.28	0.30	0.35	0.39	0.44	0.48	0.54	0.60	0.58	0.61	0.30	0.01	0.00	0.00	0.00
Cash and cash equivalents	0.06	0.06	0.05	0.04	0.11	0.38	0.40	0.13	0.12	0.13	0.17	0.15	0.26	0.39	0.44	0.48	0.54	0.60	0.58	0.61	0.30	0.01
Short-term investments	0.21	0.23	0.20	0.21	0.18	0.10	0.12	0.17	0.11	0.13	0.11	0.16	0.09
Accounts receivable, net			0.05	0.04	0.05	0.05	0.04	0.05	0.04	0.04	0.03	0.03	0.02	0.03	0.02	0.02	0.02	0.02	0.02	0.01	0.01
Inventories									0.00	0.00	0.02	0.01	0.01	-0.03	0.01	0.01	0.01	-0.02	0.01	0.01	0.00
Other current assets	0.07	0.07	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.02	0.00	0.02	0.00	0.00	0.00	0.02	0.03	0.02	0.02	0.00
Total current assets	0.35	0.37	0.31	0.30	0.35	0.54	0.57	0.36	0.28	0.32	0.33	0.35	0.38	0.44	0.48	0.52	0.58	0.63	0.61	0.64	0.31	0.01
Total non-current assets +	0.29	0.32	0.14	0.19	0.18	0.04	0.04	0.04	0.04	0.05	0.04	0.04	0.02	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00
Property, plant and equipment, net											0.01			0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill
Intangible assets
Long-term investments	0.26	0.28	0.10	0.15	0.14	0.00
Other non-current assets
Total assets	0.64	0.69	0.45	0.49	0.53	0.58	0.61	0.40	0.33	0.36	0.38	0.39	0.40	0.44	0.48	0.52	0.58	0.63	0.61	0.64	0.32	0.01

Total current liabilities +	0.04	0.04	0.03	0.03	0.02	0.06	0.03	0.03	0.03	0.04	0.03	0.03	0.03	0.04	0.04	0.03	0.03	0.02	0.03	0.02	0.02	0.01
Accounts payable	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.01	0.01	0.00
Short-term debt			0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.00	0.00	0.00						0.00			0.01
Current portion of long-term debt
Deferred revenue
Other current liabilities	0.03	0.04	0.02	0.02	0.02	0.05	0.02	0.02	0.02	0.03	0.02	0.02	0.01	0.02	0.03	0.03	0.02	0.02	0.01	0.02	0.01	0.00
Total non-current liabilities +	0.12	0.12	0.12	0.12	0.12	0.12	0.08	0.09	0.09	0.08	0.08	0.08	0.08	0.07	0.07	0.07	0.07	0.11	0.03	0.03	0.02
Long-term debt	0.11	0.11	0.11	0.11	0.11	0.11	0.08	0.08	0.08	0.08	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.08			0.00
Capital lease obligations	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Other non-current liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00				0.04	0.00	0.00	0.00	0.00	0.03	0.03
Total liabilities	0.15	0.16	0.15	0.15	0.14	0.18	0.11	0.11	0.11	0.12	0.12	0.12	0.11	0.11	0.11	0.10	0.10	0.14	0.06	0.06	0.04	0.01

Total stockholders' equity +	0.49	0.53	0.30	0.34	0.39	0.40	0.50	0.29	0.22	0.24	0.26	0.28	0.29	0.34	0.37	0.42	0.48	0.49	0.55	0.59	0.28	0.00
Common stock and paid-in capital	1.75	1.71	1.42	1.41	1.40	1.39	1.38	1.12	1.01	0.99	0.98	0.95	0.95	0.94	0.93	0.92	0.92	0.88	0.87	0.87	0.52	0.03	0.00	0.00	0.00
Retained earnings	-1.27	-1.19	-1.12	-1.07	-1.01	-0.99	-0.88	-0.83	-0.79	-0.75	-0.72	-0.68	-0.65	-0.60	-0.56	-0.50	-0.44	-0.39	-0.32	-0.28	-0.24	-0.02
Common shares outstanding	154	136	134	134	133	132	116	109	100	98	97	95	95	95	94	94	91	90	90	64	87	106	106	106	106

1 day ago

Ask a follow up

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Operating cash flow +	-0.19	-0.14	-0.16	-0.20	-0.14	-0.01	-0.01
Net income
Depreciation, depletion and amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock-based compensation	0.03	0.03	0.03	0.02	0.01	0.00	0.00
Change in inventory			0.00	0.01	0.00
Other working capital changes	-0.23	-0.18	-0.19	-0.24	-0.15	-0.01	-0.01
Cash flow from investing +	-0.42	0.03	-0.13	0.00	0.06	0.06	0.06
Capital expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Others incl. marketable securities changes	-0.42	0.03	-0.13	0.00	0.06	0.06	0.06
Cash flow from financing +	0.29	0.36	0.02	0.00	0.66	0.00	0.01
Dividend payout					0.00
Common stock repurchases					0.00	0.00	0.01
Net Debt Issuance	0.29	0.36	0.02	0.00	0.66	0.00	0.00

Change in cash	-0.32	0.25	-0.27	-0.20	0.59	0.05	0.07

Show Quarterly Cash Flow

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20
Operating cash flow +	-0.07	-0.06	-0.06	-0.02	-0.06	-0.04	-0.02	-0.04	-0.04	-0.03	-0.04	-0.04	-0.05	-0.05	-0.04	-0.06	-0.05	-0.06	-0.03	-0.03	-0.01	0.00	0.00	0.00	0.00
Net income
Depreciation, depletion and amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.00	0.00	0.00
Stock-based compensation	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in inventory										0.00	0.00	0.01	-0.01	0.00	0.00	0.00
Other working capital changes	-0.08	-0.06	-0.07	-0.03	-0.07	-0.05	-0.03	-0.05	-0.05	-0.04	-0.05	-0.06	-0.05	-0.06	-0.05	-0.07	-0.06	-0.06	-0.04	-0.04	-0.02	0.00	0.00	0.00	0.00
Cash flow from investing +	0.04	-0.22	0.06	-0.04	-0.22	0.03	0.04		0.02	-0.02	0.05	-0.07	-0.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06		0.06	0.06	0.06
Capital expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Others incl. marketable securities changes	0.04	-0.22	0.06	-0.04	-0.22	0.03	0.04	0.00	0.02	-0.02	0.05	-0.07	-0.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.00	0.06	0.06	0.06
Cash flow from financing +	0.03	0.28	0.00	0.00	0.00	0.00	0.25	0.01	0.01	0.01	0.01	0.00	0.01	0.00	0.00	0.00	0.00	0.07	0.00	0.35	0.24	0.00	0.00	0.24	0.24
Dividend payout
Common stock repurchases															0.00	0.00	0.00	0.00	0.00	0.00	0.24	0.00
Net Debt Issuance	0.03	0.28	0.00	0.00	0.00	0.00	0.25	0.01	0.01	0.01	0.01	0.00	0.01	0.00	0.00	0.00	0.00	0.07	0.00	0.35	0.00	0.00	0.00	0.24	0.24

Change in cash	0.00	0.01	0.01	-0.06	-0.28	-0.01	0.27	-0.03	-0.01	-0.04	0.03	-0.12	-0.12	-0.05	-0.04	-0.06	-0.05	0.02	-0.03	0.31	0.29	0.00	0.06	0.30	0.30

1 day ago

Ask a follow up

Centessa Pharmaceuticals plc

Income Statement - Centessa Pharmaceuticals plc (CNTA)

Income Statement - Centessa Pharmaceuticals plc (CNTA)

Balance Sheet - Centessa Pharmaceuticals plc (CNTA)

Balance Sheet - Centessa Pharmaceuticals plc (CNTA)

Cash Flow - Centessa Pharmaceuticals plc (CNTA)

Cash Flow - Centessa Pharmaceuticals plc (CNTA)